7 million will worry when Medicare coverage of anxiety medications ceases When the U.

Government’s new prescription medication benefit begins next season a group of drugs frequently used to take care of anxiety, insomnia and seizures will never be included. This will mean that those disabled and elderly people on Medicare who consider Xanax, Valium, Atvian and other styles of the medication, benzodiazepine, will have to find other means of switch or coverage to another, less addictive medicine.7 million low-income, elderly people who take the medication finding other alternatives might not be that easy. Although they’ll be automatically enrolled in the new prescription drug plan, they will be determined by the states to keep paying for their benzodiazepines but there is no guarantee that may happen. The Centers for Medicare and Medicaid Solutions have recently urged condition Medicaid directors to provide coverage of the medicines for the 6.3 million people who are eligible for prescription help under the Medicaid and Medicare applications, but only if claims agree, will they continue steadily to get federal coordinating funds when they pay for benzodiazepine..Second Quarter 2014 Results Total revenue for the next quarter of 2014 was $68.2 million, an increase of 15 percent in comparison to total revenue of $59.3 million reported in the next quarter of 2013. Total contract income for the next one fourth of 2014 was $61.5 million, an increase of 21 percent compared to contract revenue of $50.8 million reported in the second quarter of 2013. Agreement margins were 26.7 percent for the second quarter of 2014, weighed against 16.4 percent for the second quarter of 2013, driven by increased capacity utilization and the addition of Cedarburg Pharmaceuticals.